APA (7th ed.) Citation

ME, E., SE, A., SS, E., & HA, I. (2025). The potential protective effect of Empagliflozin against Cisplatin-induced ovarian damage via upregulation of SIRT1/Nrf2 and amelioration ER Stress. Inflammopharmacology, 33(11), 6887. https://doi.org/10.1007/s10787-025-01970-0

Chicago Style (17th ed.) Citation

ME, El-Sayad, Abu-Risha SE, El-Sisi SS, and Ibrahim HA. "The Potential Protective Effect of Empagliflozin Against Cisplatin-induced Ovarian Damage via Upregulation of SIRT1/Nrf2 and Amelioration ER Stress." Inflammopharmacology 33, no. 11 (2025): 6887. https://doi.org/10.1007/s10787-025-01970-0.

MLA (9th ed.) Citation

ME, El-Sayad, et al. "The Potential Protective Effect of Empagliflozin Against Cisplatin-induced Ovarian Damage via Upregulation of SIRT1/Nrf2 and Amelioration ER Stress." Inflammopharmacology, vol. 33, no. 11, 2025, p. 6887, https://doi.org/10.1007/s10787-025-01970-0.